The below is from the SEC and though it cites Nasdaq, it seems feasible that such is applicable for any market. Perhaps even more so for the smaller ones that are more vulnerable to manipulation and the corrupt activities of the sharks. If there is an exception, please feel free to let me know.
Given what BMSN has had to face with the manipulation, the screw up by Oregon State University and that they have to make some modifications to ensure their patented treatment is 100% PROTECTED by the crooks-at-large (and that includes some BP), they could very well already have approval and have appealed to the SEC to withhold this information while they make certain their property is fully protected.
If it were me, I would certainly appeal to the SEC for with holding this information as the circumstances surrounding so much with this warrant taking every step humanly possible to protect what they have worked so hard to see a reality.
I am liking the constant changes in the Google return for HemaXellerate within the FDA database.
Also, the FDA would allow so much time for the company to address the legal issues before the approval is accessible to the public by way of the FDA database. This is generally established ahead of time. However, there have been extraordinary events that have transpired since the original IND application submission.
A denial however would have to be disclosed within four days. No ifs ands or buts about it. There is nothing about disclosing such that would put the company's objectives in harms way if released. Well, there is obviously. But none that the SEC care about. If there were a denial, we would know within four days.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.